Vancouver, B.C. – January 13, 2021 (Investorideas.com Newswire) NeonMind Biosciences Inc. (CSE: NEON) (“NeonMind”), a psychedelic drug improvement firm, is happy to announce that it has engaged Dr. C. Laird Birmingham to seek the advice of with NeonMind to develop protocols for its Section 2 Medical Trial administering psilocybin to deal with overweight sufferers. Dr. Birmingham is a Specialist in Inner Drugs, an Epidemiologist and Biostatistician, and a Professor of Psychiatry on the College of British Columbia the place he was beforehand Professor of Inner Drugs, and he has in depth expertise within the design of scientific trials for therapies for consuming issues. He has additionally been appointed to NeonMind’s Board of Advisors.
Dr. Birmingham is an skilled within the therapy and research of consuming and weight issues. He has pioneered a number of new internationally acknowledged therapies. He has greater than 30 years of expertise in consuming dysfunction and weight problems analysis and therapy and has 280 publications together with 131 referenced articles, 23 invited chapters, and 9 books. He was Head of Normal Inner Drugs at St. Paul’s Hospital and UBC, Head of the Weight problems Clinic at St. Paul’s Hospital, Chief of the BC Consuming Issues Epidemiology Challenge within the Centre for Well being Analysis and Consequence Sciences, BC Provincial Director of Consuming Issues, and Medical Director of the Woodstone Residential Therapy Centre for Consuming Issues. He’s a Member of the Mind Analysis Centre at UBC.
His experience consists of consuming issues, anorexia nervosa, bulimia nervosa, binge consuming dysfunction, avoidant/restrictive meals consumption dysfunction (ARFID), phobia, emetophobia, weight problems, imaging of the mind utilizing LORETA 3D electrical mind scans, and therapy utilizing LORETA neurofeedback, vagus nerve stimulation and transcranial electrical stimulation.
Dr. Birmingham’s analysis at UBC consists of: vitamin and its relation to mind operate, ambient temperature and its impact on exercise and mind operate, malnutrition and micronutrients, and the epidemiology, problems, and therapy of consuming issues and weight problems.
Dr Birmingham says, “The issue with the therapy of weight problems is primarily that of weight upkeep. Most individuals reduce weight, however they hardly ever keep. Psilocybin has the potential to function a brand new and totally different software to assist individuals reduce weight and keep their weight reduction by altering neural pathways. Modified habits and cognitions can improve caloric expenditure associated to non-exercise and train vitality expenditure and reset the behaviours and cognitions that hyperlink life stress and trauma to consuming behaviour.”
NeonMind is at the moment conducting a preclinical trial on the College of British Columbia researching the administration of psilocybin as a therapy to assist in weight reduction and it’s now participating its full workforce to develop its Section 2 Human Medical Trial as the subsequent step in its drug improvement.
Weight problems is the trigger behind many ailments and different well being issues and has been formally acknowledged by the World Well being Group (“WHO”) as a worldwide epidemic. In line with WHO:
- 2.8 million individuals die annually on account of being chubby or overweight; and
- In 2016, greater than 1.9 billion adults, 18 years and older, had been chubby.
About NeonMind Biosciences Inc.
NeonMind is creating and commercializing merchandise that include authorized medicinal mushrooms and merchandise which will include psychedelic compounds. Its first proposed drug candidate includes the administration of psilocybin (a fancy natural compound present in psychedelic mushrooms) as a therapy for weight problems and associated sicknesses for which NeonMind has began a preclinical trial on the College of British Columbia. NeonMind has filed 5 U.S. provisional patent purposes claiming strategies of aiding in weight reduction, treating compulsive consuming dysfunction, treating weight problems or a complication of weight problems, and/or altering the eating regimen of a person by administering psilocybin and/or different psychedelic compounds or their analogues or by administering psilocybin or its analogue together with remedy or different therapies. NeonMind can be pursuing commercialization of its catalogue of proprietary medicinal mushroom product formulation. It just lately launched a set of 4 mushroom-infused coffees containing medicinal mushrooms Lion’s Mane, Turkey Tail, Reishi and Cordyceps. The NeonMind eCommerce platform launched in November 2020 at www.neonmind.com for direct to client gross sales.
Penny White, President & CEO
CEO and Principal Publicist
Exvera Communications Inc.
E mail: [email protected]
Disclaimer/Disclosure: Investorideas.com is a digital writer of third get together sourced information, articles and fairness analysis in addition to creates unique content material, together with video, interviews and articles. Authentic content material created by investorideas is protected by copyright legal guidelines apart from syndication rights. Our website doesn’t make suggestions for purchases or sale of shares, companies or merchandise. Nothing on our websites ought to be construed as a suggestion or solicitation to purchase or promote merchandise or securities. All investing includes threat and doable losses. This website is at the moment compensated for information publication and distribution, social media and advertising and marketing, content material creation and extra. Disclosure is posted for every compensated information launch, content material printed /created if required however in any other case the information was not compensated for and was printed for the only real curiosity of our readers and followers. Contact administration and IR of every firm straight concerning particular questions.
Extra disclaimer data: https://www.investorideas.com/About/Disclaimer.asp Study extra about publishing your information launch and our different information companies on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
International buyers should adhere to rules of every nation. Please learn Investorideas.com privateness coverage: https://www.investorideas.com/About/Private_Policy.asp